FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
Why Americans are outraged over health insurance — and what could change
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Health AI startup Suki expands partnership with Google Cloud to deliver more assistive tech for clinicians
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels
We're adding to our position in a stock that just landed a big Wall Street endorsement
